Evidence map›Paper›PMID 29765760›Full record

ArticleActa crystallographica. Section E, Crystallographic communications2018

2-Oxo-2

Mohammad Ouédraogo, Akoun Abou, Abdoulaye Djandé, Olivier Ouari, T Jérémie Zoueu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta crystallographica. Section E, Crystallographic communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. 2-Oxo-2IUCrData · 2025
    Article
  2. 2-Oxo-2IUCrData · 2025
    Article
  3. Synthesis and structure of 2-oxo-2Acta crystallographica. Section E, Crystallographic communications · 2025
    Article
  4. Synthesis, structure and Hirshfeld surface analysis of 2-oxo-2Acta crystallographica. Section E, Crystallographic communications · 2024
    Article
  5. Article
  6. Crystal structure of 2-oxo-2Acta crystallographica. Section E, Crystallographic communications · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohammad OuédraogoLaboratoire de Chimie Moléculaire et de Matériaux (LCMM), Equipe de Chimie Organique et de Phytochimie, Université Ouaga I Pr Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso.
Akoun AbouUnité Mixte de Recherche et d'Innovation en Electronique et d'Electricité Appliquées (UMRI EEA), Equipe de Recherche: Instrumentation Image et Spectroscopie (L2IS), DFR-GEE, Institut National Polytechnique Félix Houphouët-Boigny (INPHB), BP 1093, Yamoussoukro, Côte d'Ivoire.
Abdoulaye DjandéLaboratoire de Chimie Moléculaire et de Matériaux (LCMM), Equipe de Chimie Organique et de Phytochimie, Université Ouaga I Pr Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso.
Olivier OuariInstitut de Chimie Radicalaire, Equipe SREP, UMR 7273 Aix-Marseille Université, Avenue Escadrille Normandie-Niemen, Service 521, 13397 Marseille cedex 20, France.
T Jérémie ZoueuUnité Mixte de Recherche et d'Innovation en Electronique et d'Electricité Appliquées (UMRI EEA), Equipe de Recherche: Instrumentation Image et Spectroscopie (L2IS), DFR-GEE, Institut National Polytechnique Félix Houphouët-Boigny (INPHB), BP 1093, Yamoussoukro, Côte d'Ivoire.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the title compound, C

Indexed as

C—H⋯O hydrogen bondcoumarincrystal structureHirshfeld surface analysisquantum chemical calculations

Identifiers

PMID29765760
PMCPMC5946982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.